已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Abstract 14770: Reduction With Evolocumab in Complex Coronary Disease Requiring Revascularization: Insights From the FOURIER Trial

医学 传统PCI Evolocumab公司 血运重建 心脏病学 内科学 经皮冠状动脉介入治疗 支架 心肌梗塞 外科 载脂蛋白B 胆固醇 载脂蛋白A1
作者
Kazuma Oyama,Remo H M Furtado,Antônio Fagundes,Thomas A. Zelniker,Minao Tang,Julia Kuder,Sabina A. Murphy,Andrew Hamer,Huei Wang,Anthony Keech,Terje R. Pedersen,Robert P. Giugliano,Marc S. Sabatine,Brian Bergmark
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:142 (Suppl_3) 被引量:3
标识
DOI:10.1161/circ.142.suppl_3.14770
摘要

Introduction: Although PCSK9 inhibitors induce plaque regression and reduce the risk of coronary revascularization overall, their ability to specifically reduce the risk of complex coronary atherosclerosis requiring revascularization has not been explored. Methods: FOURIER was a randomized trial of the PCSK9 inhibitor evolocumab vs. placebo in 27,564 patients with ASCVD on statin therapy (median achieved LDL-C 32 mg/dL vs. 89 mg/dL) followed for a median of 2.2 years. The study database was blindly reviewed to assess characteristics of coronary revascularization procedures. Complex revascularization was the composite of complex PCI (per GLOBAL LEADERS criteria, at least one of: multivessel PCI, 3 or more stents implanted, 3 or more lesions treated, bifurcation PCI with 2 or more stents, or total stent length >60 mm) or CABG. PCI complications included no-reflow, side branch loss, thrombus formation, major dissection, or perforation. The effects of evolocumab on types of revascularization and PCI complications were evaluated using Cox proportional hazards models. Results: 1724 patients underwent revascularization procedures during follow-up. Evolocumab reduced the risk of non-complex PCI by 22% (HR 0.78; 95%CI 0.70-0.88; P<0.001) and the risk of complex revascularization by 29% (HR 0.71; 95%CI 0.61-0.84; P<0.001), including complex PCI by 33% (HR 0.67; 95%CI 0.54-0.84; P<0.001) and CABG by 24% (HR 0.76; 95%CI 0.60-0.96; P=0.019; Figure). The incidence of reported PCI complications tended to be lower with evolocumab (HR 0.74; 95% CI 0.49-1.11). Conclusions: Adding evolocumab to statin therapy reduced the risk of developing complex coronary disease requiring revascularization, including complex PCI and CABG individually. Together with prior coronary imaging findings, these data suggest very aggressive LDL-C lowering to <1 mmol/L has beneficial effects on coronary atherosclerosis burden, anatomical complexity, and the need for intervention.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
江米清完成签到,获得积分10
刚刚
4秒前
6秒前
7秒前
9秒前
林狗完成签到 ,获得积分10
9秒前
YJL完成签到 ,获得积分10
9秒前
浅浅完成签到,获得积分10
10秒前
HY2024发布了新的文献求助10
10秒前
sfafasfsdf完成签到,获得积分10
10秒前
斯文败类应助llll采纳,获得10
11秒前
朱锐秋发布了新的文献求助10
12秒前
15秒前
小蘑菇应助叫滚滚采纳,获得20
18秒前
22秒前
北北完成签到 ,获得积分10
23秒前
William_l_c完成签到,获得积分10
25秒前
义力古玛发布了新的文献求助10
26秒前
缥缈新梅完成签到,获得积分20
27秒前
科研通AI6.2应助悦轩风采纳,获得10
28秒前
30秒前
aerosol发布了新的文献求助10
32秒前
华仔应助朱锐秋采纳,获得10
34秒前
NexusExplorer应助朱锐秋采纳,获得10
34秒前
NexusExplorer应助朱锐秋采纳,获得10
34秒前
所所应助朱锐秋采纳,获得10
34秒前
完美世界应助朱锐秋采纳,获得10
35秒前
乐乐应助朱锐秋采纳,获得30
35秒前
36秒前
万能图书馆应助少喵几句采纳,获得10
40秒前
40秒前
Wff完成签到 ,获得积分10
41秒前
研友_VZG7GZ应助CNSSCI采纳,获得10
48秒前
49秒前
玩就过去完成签到 ,获得积分10
51秒前
52秒前
蛋蛋完成签到,获得积分10
53秒前
猫南北完成签到 ,获得积分10
53秒前
54秒前
54秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
機能性マイクロ細孔・マイクロ流体デバイスを利用した放射性核種の 分離・溶解・凝集挙動に関する研究 1000
卤化钙钛矿人工突触的研究 1000
Engineering for calcareous sediments : proceedings of the International Conference on Calcareous Sediments, Perth 15-18 March 1988 / edited by R.J. Jewell, D.C. Andrews 1000
Wolffs Headache and Other Head Pain 9th Edition 1000
Continuing Syntax 1000
Harnessing Lymphocyte-Cytokine Networks to Disrupt Current Paradigms in Childhood Nephrotic Syndrome Management: A Systematic Evidence Synthesis 700
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6253666
求助须知:如何正确求助?哪些是违规求助? 8076381
关于积分的说明 16868488
捐赠科研通 5327508
什么是DOI,文献DOI怎么找? 2836509
邀请新用户注册赠送积分活动 1813768
关于科研通互助平台的介绍 1668495